SYNTHETIC BIOLOGICS INC's ticker is and the CUSIP is 87164U409. A total of 22 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24 | -78.0% | 100 | -57.1% | 0.00% | – |
| Q1 2024 | $109 | +10.1% | 233 | +0.9% | 0.00% | – |
| Q4 2023 | $99 | +47.8% | 231 | +86.3% | 0.00% | – |
| Q3 2023 | $67 | -38.5% | 124 | +13.8% | 0.00% | – |
| Q2 2023 | $109 | +41.6% | 109 | -0.9% | 0.00% | – |
| Q1 2023 | $77 | +57.1% | 110 | +1.9% | 0.00% | – |
| Q4 2022 | $49 | – | 108 | +2.9% | 0.00% | – |
| Q3 2022 | $0 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,528 | $28,528 | 0.00% |
| ROYAL BANK OF CANADA | 7 | $0 | 0.00% |
| VANGUARD GROUP INC | 525,367 | $525,367 | 0.00% |
| Steward Partners Investment Advisory, LLC | 14 | $14 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $6 | 0.00% |
| WELLS FARGO & COMPANY/MN | 109 | $109 | 0.00% |
| NORTHERN TRUST CORP | 26,599 | $26,599 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 5,933 | $5,933 | 0.00% |
| IFP Advisors, Inc | 764 | $954 | 0.00% |